Basaglar KwikPen and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Basaglar KwikPen and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Basaglar
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Basaglar KwikPen-Insulin degludec
- Basaglar KwikPen-Insulin Degludec (U-100) Prefilled Pens
- Basaglar KwikPen-Insulin Degludec (U-100) Vials
- Basaglar KwikPen-Insulin Degludec (U-200) Prefilled Pens
- Basaglar KwikPen-Insulin degludec and liraglutide
- Basaglar KwikPen-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Basiliximab
- Insulin aspart, recombinant Subcutaneous-Basiliximab Intravenous
- Insulin aspart, recombinant Subcutaneous-Bavencio
- Insulin aspart, recombinant Subcutaneous-Baxdela
- Insulin aspart, recombinant Subcutaneous-Baxdela (Delafloxacin Injection)
- Insulin aspart, recombinant Subcutaneous-Baxdela (Delafloxacin Tablets)